Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
NCT07034859
·
clinicaltrials.gov ↗
PHASE4
Phase
ENROLLING_BY_INVITATION
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pituitary Adenoma
MRI
RCT
Interventions
DRUG:
Cabergoline 0.5 MG
Sponsor
National Taiwan University Hospital
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]